Inhibition of TGF-β, which is typically activated in HCCs with fibrous stroma [12], was reported to downregulate CCN2 and block tumor-stroma cross-talk and tumor progression in HCC [14]. This evidence concerns the gene CCN2 and hepatocellular carcinoma.